Methyl 1-isopropyl-5-oxopyrrolidine-3-carboxylate, 95.0%, 1g

1-(tert-Butoxycarbonyl)-3-hydroxypiperidine>98.0%(N)1g

OXEPAN-4-OL, 95.0%, 250mg

Scheda di sicurezza, 250 g

Benzenesulfonamide, N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]phenyl]-, 95%, 1g

5-Chloro-2-ethoxyphenylboronic acid, 95.0%, 10g

Matracci tarati classe A opachi, 500 ml, 19/26, 2 Pezzo(i)

2-Hydroxy-3-methoxy-3,3-diphenylpropanoic acid, 95.0%, 25g

2,2-Dimethyl-1,3-dioxolane-4-carbaldehyde, 98%, 500mg

tert-Butyldimethyl((2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)allyl)oxy)silane, 97%, 100mg

2-(4-(SEC-BUTOXY)-3-CYANOPHENYL)-4-METHYLTHIAZOLE-5-CARBOXYLIC ACID, 95%, 1g

3-Chloro-2-(m-tolyl)pyridine, 98%, 250mg

2-methylsulfonyl-2,6-diazaspiro[3.3]heptane;hydrochloride, 97, 250mg